Awards for “TEVA PHARMACEUTICALS USA, INC.”
25 awards on this page · sorted by amount · page 4
| Award ID | Recipient | Awarding agency | Amount | Start | End | NAICS | Description |
|---|---|---|---|---|---|---|---|
| SPE2DP21F2052 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $705.88K | 2021-02-11 | 2021-02-23 | 325412 | 8507981301!ADENOVIRUS TYPE 4 A |
| SPE2DP26F5469 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $687.05K | 2026-05-11 | 2026-05-19 | 325412 | 8512097278!ADENOVIRUS TYPE 4 A |
| SPE2DP26F4636 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $687.05K | 2026-04-15 | 2026-04-29 | 325412 | 8512042006!ADENOVIRUS TYPE 4 A |
| SPE2DP20F7222 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $678.74K | 2020-09-21 | 2020-09-29 | 325412 | 8507666470!ADENOVIRUS TYPE 4 A |
| SPE2DP26F0983 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $660.63K | 2025-12-01 | 2025-12-09 | 325412 | 8511784112!ADENOVIRUS TYPE 4 A |
| SPE2DP26F0982 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $660.63K | 2025-12-01 | 2025-12-09 | 325412 | 8511784111!ADENOVIRUS TYPE 4 A |
| SPE2DP25F109T | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $660.63K | 2025-09-08 | 2025-09-23 | 325412 | 8511624194!ADENOVIRUS TYPE 4 A |
| SPE2DP25F054S | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $660.63K | 2025-08-12 | 2025-08-26 | 325412 | 8511565391!ADENOVIRUS TYPE 4 A |
| SPE2DP25F054E | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $660.63K | 2025-08-12 | 2025-08-26 | 325412 | 8511565154!ADENOVIRUS TYPE 4 A |
| SPE2DP25F9618 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $660.63K | 2025-07-14 | 2025-07-29 | 325412 | 8511499272!ADENOVIRUS TYPE 4 A |
| SPE2DP25F8212 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $660.63K | 2025-06-16 | 2025-06-24 | 325412 | 8511446499!ADENOVIRUS TYPE 4 A |
| SPE2DP25F6736 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $660.63K | 2025-05-12 | 2025-05-20 | 325412 | 8511369395!ADENOVIRUS TYPE 4 A |
| SPE2DP25F5522 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $660.63K | 2025-04-07 | 2025-04-29 | 325412 | 8511296114!ADENOVIRUS TYPE 4 A |
| SPE2DP25F4434 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $660.63K | 2025-03-06 | 2025-03-25 | 325412 | 8511229450!ADENOVIRUS TYPE 4 A |
| SPE2DP25F4431 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $660.63K | 2025-03-06 | 2025-03-25 | 325412 | 8511229346!ADENOVIRUS TYPE 4 A |
| SPE2DP25F2791 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $660.63K | 2025-01-28 | 2025-02-04 | 325412 | 8511147949!ADENOVIRUS TYPE 4 A |
| 75P00220F80081 | TEVA PHARMACEUTICALS USA, INC. | Department of Health and Human Services | $658.44K | 2020-09-08 | 2020-10-08 | 325412 | CDC STOCKPILE |
| SPE2DP25F0859 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $635.22K | 2024-11-14 | 2024-11-19 | 325412 | 8511009835!ADENOVIRUS TYPE 4 A |
| SPE2DP25F0858 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $635.22K | 2024-11-14 | 2024-11-19 | 325412 | 8511009832!ADENOVIRUS TYPE 4 A |
| SPE2DP25F0857 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $635.22K | 2024-11-14 | 2024-11-19 | 325412 | 8511009799!ADENOVIRUS TYPE 4 A |
| SPE2DP24F7177 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $635.22K | 2024-08-22 | 2024-08-27 | 325412 | 8510840306!ADENOVIRUS TYPE 4 A |
| SPE2DP24F7167 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $635.22K | 2024-08-22 | 2024-08-27 | 325412 | 8510839844!ADENOVIRUS TYPE 4 A |
| SPE2DP24F6269 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $635.22K | 2024-07-19 | 2024-07-30 | 325412 | 8510767083!ADENOVIRUS TYPE 4 A |
| SPE2DP24F4777 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $635.22K | 2024-05-15 | 2024-05-21 | 325412 | 8510634439!ADENOVIRUS TYPE 4 A |
| SPE2DP24F4776 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $635.22K | 2024-05-15 | 2024-05-21 | 325412 | 8510634438!ADENOVIRUS TYPE 4 A |